Tag: Markets

Jim Cramer says this former Covid market darling is finally investable again

July 2, 2026 Admin No Comments

Moderna’s expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic, CNBC’s Jim Cramer said Wednesday. “For the first time in a long time, the company seems like it has something to get excited about,” the “Mad Money” host said, before advising…

Health

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

June 5, 2026 Admin No Comments

AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout the research process. “The value of AI in our industry is productivity improvement,” Soriot said on CNBC’s “Mad Money” on Friday. “In the way you design a new medicine, a new drug, you can actually do it…

Health

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

March 27, 2026 Admin No Comments

AstraZeneca‘s stock rose over 3% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift…

Health

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

February 15, 2024 Admin No Comments

It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month price targets every few weeks. To that end, we’re…

Health